Evidence map›Paper›PMID 18355417›Full record

ArticleTrials2008

Initial experience with a group presentation of study results to research participants.

Andrew L Avins, Stephen Bent, Amy Padula, Suzanne Staccone, Evelyn Badua, Harley Goldberg

Registry-linked trialAbstract read
In one paragraph

Article in Trials, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00037154 (Saw Palmetto Extract In Benign Prostatic Hyperplasia), which is not on this map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00037154 phase3completednot on this map

Saw Palmetto Extract In Benign Prostatic Hyperplasia

TypeinterventionalSponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Ran1999 to 2002Enrolled224ConditionsBenign Prostatic HyperplasiaArmsSaw Palmetto
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. The relative importance of information items and preferred mode of delivery when disseminating results from trials to participants: A mixed-methods study.Health expectations : an international journal of public participation in health care and health policy · 2022
    Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrew L AvinsDivision of Research, Northern California Kaiser Permanente, Oakland, California, USA. andrew.avins@ucsf.edu
Stephen Bent
Amy Padula
Suzanne Staccone
Evelyn Badua
Harley Goldberg

Funding

SAW PALMETTO EXTRACT IN BENIGN PROSTATIC HYPERPLASIAR01DK056199 · NIDDK · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI AVINS, ANDREW L · 1999 to 2003
$1.6M
Early Identification of Adverse Reactions to HerbsK08AT001338 · NCCIH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BENT, STEPHEN W · 2003 to 2007
$608k
NCCIH NIH HHS K08 AT001338
6 · The paper itself

Abstract

backgroundDespite ethical imperatives, informing research participants about the results of the studies in which they take part is not often performed. This is due, in part, to the costs and burdens of communicating with each participant after publication of the results.

methodsFollowing the closeout and publication of a randomized clinical trial of saw palmetto for treatment of symptoms of benign prostatic hyperplasia, patients were invited back to the research center to participate in a group presentation of the study results.

resultsApproximately 10% of participants attended one of two presentation sessions. Reaction to the experience of the group presentation was very positive among the attendees.

conclusionA group presentation to research participants is an efficient method of communicating study results to those who desire to be informed and was highly valued by those who attended. Prospectively planning for such presentations and greater scheduling flexibility may result in higher attendance rates. TRIAL REGISTRATION NUMBER: Clinicaltrials.gov #NCT00037154.

Identifiers

PMID18355417
PMCPMC2322950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.